Article
Safety and Efficacy of Mosunetuzumab: Experience in the A.O. Card G. Panico
2026-01-04
Abstract excerpt
Follicular lymphoma (FL) is the second most common form of non-Hodgkin’s lymphoma (NHL) and accounts for about 5% of all hematological malignancies. Despite therapeutic advances, FL follicular lymphoma remains an incurable disease, with frequent relapses and increasingly shorter disease control intervals. Bispecific antibodies (bsAbs) are molecules that target two different epitopes or antigens. The mechanism of a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 570cbf72-7264-54a8-9175-fd6f2d66ca64
- DOI
- 10.20944/preprints202601.0159.v1
